Jeffrey Bacha insider trades: DelMar Pharmaceuticals (DMPI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 6, 2017 | DMPI | ↑ Buy | 10,000 | $0.87 | $9K | Direct | Oct 10, 2017 (4d) |
| Jun 26, 2017 | DMPI | ↑ Buy | 6,700 | $3.60 | $24K | Direct | Jun 28, 2017 (2d) |
| Jun 6, 2017 | DMPI | ↑ Buy | 5,000 | $2.12 | $11K | Direct | Jun 6, 2017 (0d) |
| May 5, 2017 | DMPI | ↑ Buy | 2,500 | $2.20 | $6K | Direct | May 8, 2017 (3d) |
| Feb 1, 2017 | DMPI | ↑ Buy | 4,000 | $5.00 | $20K | Direct | Feb 2, 2017 (1d) |
| Nov 25, 2015 | DMPI | ↑ Buy | 7,500 | $1.47 | $11K | Direct | Nov 30, 2015 (5d) |
| Oct 8, 2015 | DMPI | ↑ Buy | 3,000 | $0.80 | $2K | Direct | Oct 9, 2015 (1d) |
| Sep 18, 2015 | DMPI | ↑ Buy | 4,000 | $0.83 | $3K | Direct | Sep 22, 2015 (4d) |
| Jul 25, 2015 | DMPI | ↑ Buy | 10,000 | $0.60 | $6K | Direct | Jul 28, 2015 (3d) |
| Jul 16, 2015 | DMPI | ↑ Buy | 50,000 | $0.60 | $30K | Direct | Jul 16, 2015 (0d) |
| Jan 22, 2015 | DMPI | ↑ Buy | 7,500 | $0.66 | $5K | Direct | Jan 22, 2015 (0d) |
| Dec 9, 2014 | DMPI | ↑ Buy | 2,500 | $0.90 | $2K | Direct | Dec 10, 2014 (1d) |
| Nov 26, 2014 | DMPI | ↑ Buy | 2,500 | $0.92 | $2K | Direct | Nov 26, 2014 (0d) |
| Sep 18, 2014 | DMPI | ↑ Buy | 4,000 | $0.98 | $4K | Direct | Sep 19, 2014 (1d) |
| Sep 15, 2014 | DMPI | ↑ Buy | 4,985 | $0.75 | $4K | Direct | Sep 16, 2014 (1d) |
| Mar 18, 2014 | DMPI | ↑ Buy | 10,000 | $1.30 | $13K | Direct | Mar 20, 2014 (2d) |
| Feb 21, 2014 | DMPI | ↑ Buy | 5,000 | $1.00 | $5K | Direct | Feb 21, 2014 (0d) |
| Feb 13, 2014 | DMPI | ↑ Buy | 5,000 | $0.80 | $4K | Direct | Feb 13, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jeffrey Bacha's insider trades
Jeffrey Bacha is a director at DelMar Pharmaceuticals (DMPI). Since Feb 13, 2014, Jeffrey has reported 18 open-market purchases worth $161K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (11 filings), grants and awards (3 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DMPI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.